Regulon

Regulon: R-3371

Regulons are regulatory units consisting of a coherently expressed set of genes and the associated regulator(s) whose binding site(s) they share.

Regulon Summary

Regulon summary table displays all associated information related to the specific regulon including the number of genes in the regulon, Hazard ratio, its Regulator, the Transcriptional Program that includes the regulon, Drugs that are associated with members of the regulon, together with mechanism of action and class, and enriched hallmarks of cancer if any.

GenesCox Hazard RatioRegulatorsCausal FlowsTranscriptional ProgramsHallmarks
52.5283617Pr-7Self sufficiency in growth signalInsensitivity to antigrowth signalEvading apoptosisSustained angiogenesisTissue invasion and metastasisTumor-promoting inflammationReprogramming energy metabolismEvading immune detectionLimitless replicative potentialGenome instability and mutation

Regulon Genes

List of genes that are included in the regulon. These genes have similar expression profiles in subset of patients and they share common binding motif for the Regulator of the regulon. Clicking on the gene name will take you to the gene specific page with more details. Please wait while information is collated from several resources after you click.

Entrez IDEnsEMBL IDPreferred NameUniprot ID
51338 ENSG00000110079 MS4A4A Q96JQ5
241 ENSG00000132965 ALOX5AP P20292
3689 ENSG00000160255 ITGB2 D3DSM0
719 ENSG00000171860 C3AR1 Q16581
3903 ENSG00000278154 LAIR1 Q6GTX8

Regulon Drugs

NameApproved SymbolTypeAction TypeMechanism of ActionMax Trial PhaseMax GBM Phase
FIBOFLAPON SODIUMALOX5APSmall moleculeINHIBITOR5-lipoxygenase activating protein inhibitor30
AME-133VITGB2AntibodyINHIBITORIntegrin beta-2 inhibitor20
EFALIZUMABITGALAntibodyINHIBITORIntegrin alpha-L/beta-2 (LFA-1) inhibitor40
LIFITEGRASTITGALSmall moleculeANTAGONISTIntegrin alpha-L/beta-2 (LFA-1) antagonist40
VELIFLAPONALOX5APSmall moleculeINHIBITOR5-lipoxygenase activating protein inhibitor30
FIBOFLAPONALOX5APSmall moleculeINHIBITOR5-lipoxygenase activating protein inhibitor30

Causal Flows

Causal Flows are statistically significant links between putative causal events (somatic mutations, copy number variations, chromosomal translocations, etc.) and the activity levels of regulators and regulons. In the causal flow a mutation may causally activates or deactivates a downstream regulator which then might up- or down-regulates a regulon that contains genes with similar expression profiles and binding sites.

Causal Mechanistic Flows for Regulon R-3371

IDMutationRoleRegulatorRoleRegulon# downstream regulons# diffexp regulonsDrugs
CMF-00759DNAH5up-regulatesMAFFactivatesR-337122Drugs (6)

Regulator Drugs (0)

Regulon Drugs (6)

FIBOFLAPON SODIUM, AME-133V, EFALIZUMAB, LIFITEGRAST, VELIFLAPON, FIBOFLAPON

CMF-01637MCM6up-regulatesMAFFactivatesR-337122Drugs (6)

Regulator Drugs (0)

Regulon Drugs (6)

FIBOFLAPON SODIUM, AME-133V, EFALIZUMAB, LIFITEGRAST, VELIFLAPON, FIBOFLAPON

CMF-07177ATRXdown-regulatesMAFFactivatesR-337122Drugs (6)

Regulator Drugs (0)

Regulon Drugs (6)

FIBOFLAPON SODIUM, AME-133V, EFALIZUMAB, LIFITEGRAST, VELIFLAPON, FIBOFLAPON

CMF-07863TNK2down-regulatesMAFFactivatesR-337122Drugs (6)

Regulator Drugs (0)

Regulon Drugs (6)

FIBOFLAPON SODIUM, AME-133V, EFALIZUMAB, LIFITEGRAST, VELIFLAPON, FIBOFLAPON

CMF-13878ADAMTS8down-regulatesMAFFactivatesR-337122Drugs (6)

Regulator Drugs (0)

Regulon Drugs (6)

FIBOFLAPON SODIUM, AME-133V, EFALIZUMAB, LIFITEGRAST, VELIFLAPON, FIBOFLAPON

CMF-15962KCNB2up-regulatesMAFFactivatesR-337122Drugs (6)

Regulator Drugs (0)

Regulon Drugs (6)

FIBOFLAPON SODIUM, AME-133V, EFALIZUMAB, LIFITEGRAST, VELIFLAPON, FIBOFLAPON

CMF-27565JPH2up-regulatesMAFFactivatesR-337121Drugs (6)

Regulator Drugs (0)

Regulon Drugs (6)

FIBOFLAPON SODIUM, AME-133V, EFALIZUMAB, LIFITEGRAST, VELIFLAPON, FIBOFLAPON